Cemex S.A.B. De C.V. ADR (CX) concluded trading on Wednesday at a closing price of $5.58, with 7.09 million shares of worth about $39.58 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -13.35% during that period and on January 22, 2025 the price saw a gain of about 1.27%. Currently the company’s common shares owned by public are about 1.51B shares, out of which, 1.51B shares are available for trading.
Stock saw a price change of 3.33% in past 5 days and over the past one month there was a price change of 0.72%. Year-to-date (YTD), CX shares are showing a performance of -1.06% which decreased to -25.20% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $5.00 but also hit the highest price of $9.27 during that period. The average intraday trading volume for Cemex S.A.B. De C.V. ADR shares is 10.77 million. The stock is currently trading -0.13% below its 20-day simple moving average (SMA20), while that difference is down -0.33% for SMA50 and it goes to -13.07% lower than SMA200.
Cemex S.A.B. De C.V. ADR (NYSE: CX) currently have 1.51B outstanding shares and institutions hold larger chunk of about 30.02% of that.
The stock has a current market capitalization of $8.44B and its 3Y-monthly beta is at 1.49. PE ratio of stock for trailing 12 months is 18.21, while it has posted earnings per share of $0.31 in the same period. It has Quick Ratio of 0.73 while making debt-to-equity ratio of 0.62. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CX, volatility over the week remained 3.07% while standing at 2.65% over the month.
Analysts are in expectations that Cemex S.A.B. De C.V. ADR (CX) stock would likely to be making an EPS of 0 in the current quarter, while forecast for next quarter EPS is 0 and it is 0.76 for next year. For the current quarter EPS, analysts have given the company a lowest target 0 which is 0 at the higher side of the target for the same. Stock’s fiscal year EPS is expected to rise by 608.23% while it is estimated to increase by 1.69% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by RBC Capital Mkts on December 11, 2024 offering an Underperform rating for the stock and assigned a target price range of between $6 and $5 to it. Coverage by JP Morgan stated Cemex S.A.B. De C.V. ADR (CX) stock as a Neutral in their note to investors on October 29, 2024, suggesting a price target of $6 for the stock. On October 08, 2024, RBC Capital Mkts Upgrade their recommendations, while on August 21, 2024, JP Morgan Resumed their ratings for the stock with a price target of $8. Stock get an Overweight rating from Barclays on July 31, 2024.
